NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized invest

In September, embecta will participate in the Wells Fargo 2026 Healthcare Conference and the J.P. Mo

New York, New York--(Newsfile Corp. - August 26, 2026) - Bernstein Liebhard LLP, a nationally recogn

Embecta offers a compelling deep value opportunity, trading at a P/E below 3x and free cash flow yie

New York, New York--(Newsfile Corp. - August 18, 2026) - Bernstein Liebhard LLP, a nationally recogn

A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stoc

NEW YORK--(BUSINESS WIRE)---- $EMBC #ClassAction--Faruqi & Faruqi, LLP, a leading national securitie

EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit PR New

NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds p

NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogni

LOS ANGELES--(BUSINESS WIRE)---- $EMBC--EMBC Investors Have Opportunity to Lead Embecta Corp. Securi

NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP

LOS ANGELES, Aug. 17, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehol

LOS ANGELES, Aug. 17, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action law

NEW YORK, Aug. 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

New York, New York--(Newsfile Corp. - August 16, 2026) - WHY: Rosen Law Firm, a global investor righ

INVESTOR DEADLINE APPROACHING: Faruqi and Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities

Faruqi & Faruqi, LLP Securities Litigation Partner  James (Josh) Wilson  Encourages Investors Who Su

New York, New York--(Newsfile Corp. - August 15, 2026) - WHY: Rosen Law Firm, a global investor righ

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.

Embecta (NASDAQ:EMBC) raises FY2026 Adj EPS guidance from $1.55-$1.75 to $1.80-$1.90 vs $1.59 analys

B of A Securities analyst Travis Steed maintains Embecta (NASDAQ:EMBC) with a Underperform and lo

Mizuho analyst Anthony Petrone maintains Embecta (NASDAQ:EMBC) with a Neutral and lowers the pric

US stocks rise, Nasdaq gains 1%. Dow up 0.57%, Nasdaq up 1.03%, S&P 500 up 0.84%. Materials up 2

US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 e

Embecta (NASDAQ:EMBC) lowers FY2026 Adj EPS guidance from $2.80-$3.00 to $1.55-$1.75 vs $2.81 analys

Embecta (NASDAQ:EMBC) reported quarterly earnings of $0.27 per share which missed the analyst consen

Embecta Corp. ("Embecta") (NASDAQ:EMBC), a global leader in diabetes care technology, today

Embecta (NASDAQ:EMBC) affirms FY2026 Adj EPS guidance from $2.80-$3.00 to $2.80-$3.00 vs $2.91 analy

Embecta (NASDAQ:EMBC) reported quarterly earnings of $0.71 per share which beat the analyst consensu

Preliminary Fiscal Year 2026 Financial Guidance:For fiscal year 2026, the Company expects:Dollars in

Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year leg

Fiscal Year 2025 Updated Financial Guidance:For fiscal year 2025, the Company now expects:Dollars in

Mizuho analyst Anthony Petrone maintains Embecta (NASDAQ:EMBC) with a Neutral and lowers the pric

Mizuho analyst Anthony Petrone maintains Embecta (NASDAQ:EMBC) with a Neutral and lowers the pric

Embecta Corp. ("embecta"; "The Company") (NASDAQ:EMBC), a global diabetes care compa